The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
CorrectionFull Access

Correction to Mattes

When the letter “Ketamine After Two Antidepressants?” by Jeffrey A. Mattes, M.D. (doi: 10.1176/appi.ajp.2021.21060576) was published in the December 2021 issue, three words (“and augmenting agents”) were missing from a portion of the first sentence, which should have read “there is considerable data (2) indicating that other antidepressants (either alone or combined), and augmenting agents such as lithium, thyroxine, etc., can help patients who have not responded to prior antidepressants.” The letter was reposted online on January 28, 2022, with the words added.